MSR1 and Alzheimer disease: In mouse models of AD, Msr1 deficiency impairs clearance of soluble Aβ and results in increased Aβ deposition and early mortality, whereas pharmacological upregulation of Msr1 leads to enhanced Aβ clearance [21, 22].